SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending due to Hapag-Lloyd's agreed acquisition at $35 per share, sparking widespread community discussion around potential short squeezes and whether the Israeli government will approve the deal amid national security concerns and a long closing timeline.

PepeCoin is a meme token based on the character Pepe the Frog. Initially launched in March 2016 on its own blockchain, it later migrated to Ethereum. PepeCoin is recognized as the original Pepe currency due to its long history.   The project aims to provide a variety of use cases, transforming PepeCoin into a memecoin with utility.  The community is primarily focused on creating a fun atmosphere, actively engaging in various events to enhance the token's growth and visibility. Additionally, PepeCoin is developing a game that will serve as an interactive social Web 3.0 video game platform, further expanding its ecosystem and fostering interaction among users.

PepeCoin

PEPECOIN CRYPTO is actively trending as its community emphasizes its status as the original, mineable Pepe asset, contrasting it with the more widely recognized $PEPE meme token. Supporters point to its deflationary model, real utility within projects like BasedAI, and upcoming developments like Kekspace as catalysts for significant potential.

Fiverr International Ltd. develops an e-commerce platform that allows people to buy and sell digital services. It operates through the following geographical segments: U.S., Europe, Asia Pacific, Rest of the World and Israel. The firm offers digital marketing, graphics and design, video and animation, writing and translation, and music and audio. The company was founded by Micha Kaufman and Shai Wininger in 2009 and is headquartered in Tel Aviv, Israel.

Fiverr International Ltd

Fiverr International is generating significant discussion after its recent earnings beat, raised guidance, and a strategic restructuring including job cuts and an expanded share buyback program. The community is actively debating whether AI will be a powerful tailwind, creating new demands for augmented human skills and making the stock deeply undervalued, or an existential threat to the gig economy.

BlockDAG

BlockDAG is trending amid widespread community frustration and escalating concerns over its prolonged presale, confusing launch timelines, and persistent reports of users unable to claim their purchased tokens, fueling rampant speculation about the project's legitimacy and fears of a potential scam.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors eagerly await the imminent release of topline Phase 3 data for its wet AMD treatment, AXPAXLI. The community is buzzing with speculation about a potential acquisition by Sanofi at a significantly higher bid than previously offered, alongside strong bullish sentiment driven by management's strategic data presentation at a major retina conference and recent institutional accumulation, despite the inherent binary risk of the biotech catalyst.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is seeing highly divided sentiment as futures trading points to mixed signals ahead of the market open, with community members actively debating a potential rebound against ongoing concerns about economic conditions and tech sector performance.

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Savara Inc

Savara Inc. is trending due to overwhelmingly positive Phase 3 trial results for Molgramostim, its lead candidate for autoimmune PAP, a rare lung disease with no approved therapies. This success has sparked significant investor optimism for potential FDA approval and market opportunity, along with a flurry of analyst upgrades and active speculation about a potential acquisition.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing intense debate and high volatility as the market anticipates key macroeconomic reports and upcoming major tech earnings, notably from Nvidia. Bears are vocal about technical weakness and AI disruption fears, predicting a significant market pullback, while bulls anticipate a strong rebound, viewing current tech valuations as attractive and market fears as exaggerated.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid intense speculation of a potential buyout by major tech giants like SpaceX or Amazon, driven by its valuable n53 spectrum and expanding Apple partnership. The community is focused on upcoming FCC decisions for spectrum use and its C-3 constellation, which are viewed as key catalysts for its undervalued direct-to-device and private network capabilities.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs (CLF) is a hot topic as investors weigh a mixed earnings report and news of the CEO's share sale, igniting concerns over management and the company's debt load. However, a segment of the community is buying the dip, optimistic about the 2026 outlook with anticipated cost reductions, increased steel shipments, and ongoing strategic partnership talks with POSCO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Rating of "Hold" from Brokerages

Shares of MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) have received an average recommendation of "Hold" from the five ratings firms that are presently covering the stock, MarketBeat.com...

MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of "Hold" from Analysts

Shares of MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) have been given an average rating of "Hold" by the five research firms that are currently covering the company, MarketBeat Ratings...

Wall Street Zen Upgrades MiNK Therapeutics (NASDAQ:INKT) to "Hold"

Wall Street Zen raised shares of MiNK Therapeutics from a "sell" rating to a "hold" rating in a research report on Monday...

MiNK Therapeutics (NASDAQ:INKT) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen cut shares of MiNK Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...

MiNK Therapeutics (NASDAQ:INKT) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised MiNK Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...

MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Rating of "Hold" from Analysts

MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) has earned an average rating of "Hold" from the five research firms that are presently covering the stock, Marketbeat reports. One equities...

Wall Street Zen Downgrades MiNK Therapeutics (NASDAQ:INKT) to Sell

Wall Street Zen downgraded MiNK Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Wall Street Zen upgraded shares of MiNK Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Average Recommendation of "Hold" from Brokerages

Shares of MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) have received a consensus rating of "Hold" from the five ratings firms that are presently covering the stock, Marketbeat reports. One...

MiNK Therapeutics (NASDAQ:INKT) Posts Earnings Results, Beats Expectations By $0.21 EPS

MiNK Therapeutics (NASDAQ:INKT - Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.65) earnings per share (EPS) for the quarter, beating analysts' consensus...

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

MiNK Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

INKT
MiNK Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest INKT News

INKTMiNK Therapeutics Inc